Receptor tyrosine kinase (RTK) signaling triggers cell growth and blocks apoptosis, enhancing cancer cell survival and proliferation in the presence of platinum and other anti-cancer drugs [112, 113]. This evidence concerns the gene NTRK1 and cancer.